1: Schittenhelm MM, Kaiser M, Győrffy B, Kampa-Schittenhelm KM. Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML). Cell Death Dis. 2024 Jan 10;15(1):25. doi: 10.1038/s41419-023-06372-0. PMID: 38195541; PMCID: PMC10776670.
2: Dobson L, Gerdán C, Tusnády S, Szekeres L, Kuffa K, Langó T, Zeke A, Tusnády GE. UniTmp: unified resources for transmembrane proteins. Nucleic Acids Res. 2024 Jan 5;52(D1):D572-D578. doi: 10.1093/nar/gkad897. PMID: 37870462; PMCID: PMC10767979.
3: Kumar M, Michael S, Alvarado-Valverde J, Zeke A, Lazar T, Glavina J, Nagy-Kanta E, Donagh JM, Kalman ZE, Pascarelli S, Palopoli N, Dobson L, Suarez CF, Van Roey K, Krystkowiak I, Griffin JE, Nagpal A, Bhardwaj R, Diella F, Mészáros B, Dean K, Davey NE, Pancsa R, Chemes LB, Gibson TJ. ELM-the Eukaryotic Linear Motif resource-2024 update. Nucleic Acids Res. 2024 Jan 5;52(D1):D442-D455. doi:10.1093/nar/gkad1058. PMID: 37962385; PMCID: PMC10767929.
4: Pan X, AbdulJabbar K, Coelho-Lima J, Grapa AI, Zhang H, Cheung AHK, Baena J, Karasaki T, Wilson CR, Sereno M, Veeriah S, Aitken SJ, Hackshaw A, Nicholson AG, Jamal-Hanjani M; TRACERx Consortium; Swanton C, Yuan Y, Le Quesne J, Moore DA. The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma. Nat Cancer. 2024 Jan 10. doi: 10.1038/s43018-023-00694-w. Epub ahead of print. PMID: 38200244.
5: Zhou W, Zhao Z, Lin A, Yang J, Xu J, Kari WR, Yang A, Li J, Solanki S, Speth J, Walker N, Scott AJ, Kothari AU, Yao Y, Peterson ER, Korimerla N, Werner CK, Liang J, Jacobson J, Palavalasa S, Obrien AM, Elaimy AL, Ferris SP, Zhao SG, Sarkaria JN, Győrffy B, Zhang S, Al-Holou WN, Umemura Y, Morgan MA, Lawrence TS, Lyssiotis CA, Peters-Golden M, Shah YM, Wahl DR. GTP signaling links metabolism, DNA repair, and responses to genotoxic stress. bioRxiv [Preprint]. 2023 Apr 13:2023.04.12.536297. doi: 10.1101/2023.04.12.536297. Update in: Cancer Discov. 2023 Oct 30;: PMID: 37090571; PMCID: PMC10120670.
6: Győrffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024 Feb;181(3):362-374. doi: 10.1111/bph.16257. Epub 2023 Nov 23. PMID: 37783508.
7: Aspromonte MC, Nugnes MV, Quaglia F, Bouharoua A; DisProt Consortium; Tosatto SCE, Piovesan D. DisProt in 2024: improving function annotation of intrinsically disordered proteins. Nucleic Acids Res. 2024 Jan 5;52(D1):D434-D441. doi: 10.1093/nar/gkad928. PMID: 37904585; PMCID: PMC10767923.
8: Menyhárt O, Fekete JT, Győrffy B. Resistance to Combined Anthracycline-Taxane Chemotherapy Is Associated with Altered Metabolism and Inflammation in Breast Carcinomas. Int J Mol Sci. 2024 Jan 15;25(2):1063. doi: 10.3390/ijms25021063. PMID: 38256136; PMCID: PMC10816584.
9: Menyhárt O, Győrffy B. Dietary approaches for exploiting metabolic vulnerabilities in cancer. Biochim Biophys Acta Rev Cancer. 2023 Dec 28;1879(2):189062. doi: 10.1016/j.bbcan.2023.189062. Epub ahead of print. PMID: 38158024.
10: Zeke A, Gibson TJ, Dobson L. Linear motifs regulating protein secretion, sorting and autophagy in Leishmania parasites are diverged with respect to their host equivalents. PLoS Comput Biol. 2024 Feb 16;20(2):e1011902. doi: 10.1371/journal.pcbi.1011902. Epub ahead of print. PMID: 38363808.
11: Baca SC, Seo JH, Davidsohn MP, Fortunato B, Semaan K, Sotudian S, Lakshminarayanan G, Diossy M, Qiu X, El Zarif T, Savignano H, Canniff J, Madueke I, Saliby RM, Zhang Z, Li R, Jiang Y, Taing L, Awad M, Chau CH, DeCaprio JA, Figg WD, Greten TF, Hata AN, Hodi FS, Hughes ME, Ligon KL, Lin N, Ng K, Oser MG, Meador C, Parsons HA, Pomerantz MM, Rajan A, Ritz J, Thakuria M, Tolaney SM, Wen PY, Long H, Berchuck JE, Szallasi Z, Choueiri TK, Freedman ML. Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping. Nat Med. 2024 Mar;30(3):907. doi: 10.1038/s41591-023-02735-4. Erratum for: Nat Med. 2023 Nov;29(11):2737-2741. PMID: 38049623; PMCID: PMC10957463.
12: Sanvicente A, Díaz-Tejeiro C, Nieto-Jiménez C, Paniagua-Herranz L, López Cade I, Balázs Győrffy, Moreno V, Pérez-Segura P, Calvo E, Ocaña A. In Silico Transcriptomic Expression of MSR1 in Solid Tumors Is Associated with Responses to Anti-PD1 and Anti-CTLA4 Therapies. Int J Mol Sci. 2024 Apr 3;25(7):3987. doi: 10.3390/ijms25073987. PMID: 38612803; PMCID: PMC11012116.
13: Prosz A, Sahgal P, Huffman BM, Sztupinszki Z, Morris CX, Chen D, Börcsök J, Diossy M, Tisza V, Spisak S, Likasitwatanakul P, Rusz O, Csabai I, Cecchini M, Baca Y, Elliot A, Enzinger P, Singh H, Ubellaker J, Lazaro JB, Cleary JM, Szallasi Z, Sethi NS. Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. NPJ Precis Oncol. 2024 Apr 8;8(1):87. doi: 10.1038/s41698-024-00561-6. PMID: 38589664; PMCID: PMC11001913.
14: Bácsi I, Figler A, Simon E, Yaqoob MM, Márton K, B-Béres V. Salinity tolerance and desalination properties of a <i>Haematococcus lacustris</i> strain from eastern Hungary. Front Microbiol. 2024 Mar 14;15:1332642. doi: 10.3389/fmicb.2024.1332642. PMID: 38550863; PMCID: PMC10977603.
15: Smith K, Beach D, Silva R, Balazs Győrffy, Salani F, Crea F. Comprehensive analysisnof differentially expressed miRNAs in hepatocellular carcinoma: Prognostic, predictive significance and pathway insights. PLoS One. 2024 Apr 18;19(4):e0296198. doi: 10.1371/journal.pone.0296198. PMID: 38635644; PMCID: PMC11025735.
16: Ungvari Z, Ungvari A, Bianchini G, Győrffy B. Prognostic significance of a signature based on senescence-related genes in colorectal cancer. Geroscience. 2024 Apr 25. doi: 10.1007/s11357-024-01164-6. Epub ahead of print. PMID: 38658505.
17: Parreno V, Loubiere V, Schuettengruber B, Fritsch L, Rawal CC, Erokhin M, Győrffy B, Normanno D, Di Stefano M, Moreaux J, Butova NL, Chiolo I, Chetverina D, Martinez AM, Cavalli G. Transient loss of Polycomb components induces an epigenetic cancer fate. Nature. 2024 Apr 24. doi: 10.1038/s41586-024-07328-w. Epub ahead of print. PMID: 38658752.
18. Sanvicente García A, Pedregal M, Paniagua-Herranz L, Díaz-Tejeiro C, Nieto- Jiménez C, Pérez Segura P, Munkácsy G, Győrffy B, Calvo E, Moreno V, Ocaña A.
Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D. Int J Mol Sci. 2024 May 14;25(10):5345. doi: 10.3390/ijms25105345. PMID: 38791382; PMCID: PMC11121234.
19.: Prosz A, Sahgal P, Huffman BM, Sztupinszki Z, Morris CX, Chen D, Börcsök J, Diossy M, Tisza V, Spisak S, Likasitwatanakul P, Rusz O, Csabai I, Cecchini M, Baca Y, Elliott A, Enzinger P, Singh H, Ubellaker J, Lazaro JB, Cleary JM, Szallasi Z, Sethi NS. Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. NPJ Precis Oncol. 2024 Apr 8;8(1):87. doi: 10.1038/s41698-024-00561-6. Erratum in: NPJ Precis Oncol. 2024 May 6;8(1):98. PMID: 38589664; PMCID: PMC11001913.
20: Rosano D, Sofyali E, Dhiman H, Ghirardi C, Ivanoiu D, Heide T, Vingiani A, Bertolotti A, Pruneri G, Canale E, Dewhurst HF, Saha D, Slaven N, Barozzi I, Li T, Zemlyanskiy G, Phillips H, James C, Győrffy B, Lynn C, Cresswell GD, Rehman F, Noberini R, Bonaldi T, Sottoriva A, Magnani L. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells. Cancer Discov. 2024 May 1;14(5):866-889. doi: 10.1158/2159-8290.CD-23-1161. PMID: 38527495; PMCID: PMC11061610.
21: Szadai L, Bartha A, Parada IP, Lakatos A, Pál D, Lengyel AS, de Almeida NP, Jánosi ÁJ, Nogueira F, Szeitz B, Doma V, Woldmar N, Guedes J, Ujfaludi Z, Pahi
ZG, Pankotai T, Kim Y, Győrffy B, Baldetorp B, Welinder C, Szasz AM, Betancourt L, Gil J, Appelqvist R, Kwon HJ, Kárpáti S, Kuras M, Murillo JR, Németh IB, Malm
J, Fenyö D, Pawłowski K, Horvatovich P, Wieslander E, Kemény LV, Domont G, MarkoVarga G, Sanchez A. Predicting immune checkpoint therapy response in three
independent metastatic melanoma cohorts. bioRxiv [Preprint]. 2024 May 4:2024.05.01.592032. doi: 10.1101/2024.05.01.592032. PMID: 38746333; PMCID: PMC11092593.
22. Parreno V, Loubiere V, Schuettengruber B, Fritsch L, Rawal CC, Erokhin M, Győrffy B, Normanno D, Di Stefano M, Moreaux J, Butova NL, Chiolo I, Chetverina
D, Martinez AM, Cavalli G. Transient loss of Polycomb components induces an epigenetic cancer fate. Nature. 2024 May;629(8012):688-696. doi: 10.1038/s41586-024-07328-w. Epub 2024 Apr 24. PMID: 38658752; PMCID: PMC11096130.
23: Noblejas-López MDM, García-Gil E, Pérez-Segura P, Pandiella A, Győrffy B, Ocaña A. T-reg transcriptomic signatures identify response to check-point inhibitors. Sci Rep. 2024 May 6;14(1):10396. doi: 10.1038/s41598-024-60819-8. PMID: 38710724; PMCID: PMC11074113.
24: Spisak S, Chen D, Likasitwatanakul P, Doan P, Li Z, Bala P, Vizkeleti L, Tisza V, De Silva P, Giannakis M, Wolpin B, Qi J, Sethi NS. Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer. bioRxiv [Preprint]. 2024 Jan 17:2023.06.21.545895. doi: 10.1101/2023.06.21.545895. Update in: Nat Commun. 2024 Mar 12;15(1):2230. PMID: 38293113; PMCID: PMC10827082.
25: Győrffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 2024 Apr 9;5(3):100625. doi: 10.1016/j.xinn.2024.100625. PMID: 38706955; PMCID: PMC11066458.
26: Edtmayer S, Witalisz-Siepracka A, Zdársky B, Heindl K, Weiss S, Eder T, Dutta S, Graichen U, Klee S, Sharif O, Wieser R, Győrffy B, Poli V, Casanova E, Sill H, Grebien F, Stoiber D. A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia. Cell Death Dis. 2024 May 28;15(5):369. doi: 10.1038/s41419-024-06749-9. PMID: 38806478; PMCID: PMC11133483.
27: Lukácsi S, Munkácsy G, Győrffy B. Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies. Integr Cancer Ther. 2024 Jan-Dec;23:15347354241242094. doi: 10.1177/15347354241242094. PMID: 38818970; PMCID: PMC11143831.
28: Park SH, Ju JS, Woo H, Yun HJ, Lee SB, Kim SH, Győrffy B, Kim EJ, Kim H, Han HD, Eyun SI, Lee JH, Park YY. The m<sup>6</sup>A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolism. Exp Mol Med. 2024 Jun 3. doi: 10.1038/s12276-024-01235-w. Epub ahead of print. PMID: 38825643.
29: Park SH, Ju JS, Woo H, Yun HJ, Lee SB, Kim SH, Győrffy B, Kim EJ, Kim H, Han HD, Eyun SI, Lee JH, Park YY. The m<sup>6</sup>A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolism. Exp Mol Med. 2024 Jun 3. doi: 10.1038/s12276-024-01235-w. Epub ahead of print. PMID: 38825643.
30: Lukácsi S, Munkácsy G, Győrffy B. Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies. Integr Cancer Ther. 2024 Jan-Dec;23:15347354241242094. doi: 10.1177/15347354241242094. PMID: 38818970; PMCID: PMC11143831.
31: Edtmayer S, Witalisz-Siepracka A, Zdársky B, Heindl K, Weiss S, Eder T, Dutta S, Graichen U, Klee S, Sharif O, Wieser R, Győrffy B, Poli V, Casanova E, Sill H, Grebien F, Stoiber D. A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia. Cell Death Dis. 2024 May 28;15(5):369. doi: 10.1038/s41419-024-06749-9. PMID: 38806478; PMCID: PMC11133483.
32: Witalisz-Siepracka A, Denk CM, Zdársky B, Hofmann L, Edtmayer S, Harm T, Weiss S, Heindl K, Hessenberger M, Summer S, Dutta S, Casanova E, Obermair GJ, Győrffy B, Putz EM, Sill H, Stoiber D. STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillance. Front Immunol. 2024 Jul 5;15:1374068. doi: 10.3389/fimmu.2024.1374068. PMID: 39034990; PMCID: PMC11257888.
33: Pinto de Almeida N, Jánosi ÁJ, Hong R, Rajeh A, Nogueira F, Szadai L, Szeitz B, Pla Parada I, Doma V, Woldmar N, Guedes J, Újfaludi Z, Bartha A, Kim Y, Welinder C, Baldetorp B, Kemény LV, Pahi Z, Wan G, Nguyen N, Pankotai T, Győrffy B, Pawłowski K, Horvatovich P, Szasz AM, Sanchez A, Kuras M, Rodriguez Murillo J, Betancourt L, Domont GB, Semenov YR, Yu KH, Kwon HJ, Németh IB, Fenyő D, Wieslander E, Marko-Varga G, Gil J. Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma. Clin Transl Med. 2024 Jul;14(7):e1773. doi: 10.1002/ctm2.1773. PMID: 39032005; PMCID: PMC11259597.
34: Paniagua-Herranz L, Moreno I, Nieto-Jiménez C, Garcia-Lorenzo E, Díaz-Tejeiro C, Sanvicente A, Doger B, Pedregal M, Ramón J, Bartolomé J, Manzano A, Gyorffy B, Gutierrez-Uzquiza Á, Pérez Segura P, Calvo E, Moreno V, Ocana A. Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2. Int J Mol Sci. 2024 Feb 13;25(4):2222. doi: 10.3390/ijms25042222. PMID: 38396898; PMCID: PMC10889228.
35: Ungvari Z, Fekete M, Fekete JT, Grosso G, Ungvari A, Győrffy B. Adherence to the Mediterranean diet and its protective effects against colorectal cancer: a meta-analysis of 26 studies with 2,217,404 participants. Geroscience. 2024 Aug 1. doi: 10.1007/s11357-024-01296-9. Epub ahead of print. PMID: 39090501.
36: Menyhart O, Fekete JT, Győrffy B. Inflammation and Colorectal Cancer: A Meta- Analysis of the Prognostic Significance of the Systemic Immune-Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI). Int J Mol Sci. 2024 Aug 2;25(15):8441. doi: 10.3390/ijms25158441. PMID: 39126008; PMCID: PMC11312822.
37: Major E, Lin KH, Lee SC, Káldi K, Győrffy B, Tigyi GJ, Benyó Z. LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10. Acta Pharmacol Sin. 2024 Aug 26. doi: 10.1038/s41401-024-01373-x. Epub ahead of print. PMID: 39187677.
38: Sziklavari Z, Hammoudeh S, Petrone AM, Stange S, Orban K, Fekete JT, Hofmann HS. Outcomes of Vacuum-Assisted Closure in Patients with Empyema Thoracis: A 10-Year Experience. Ann Thorac Surg. 2024 Aug 22:S0003-4975(24)00677-5. doi: 10.1016/j.athoracsur.2024.08.003. Epub ahead of print. PMID: 39178929.
39: Barozzi I, Slaven N, Canale E, Lopes R, Amorim Monteiro Barbosa I, Bleu M, Ivanoiu D, Pacini C, Mensa’ E, Chambers A, Bravaccini S, Ravaioli S, Győrffy B, Dieci MV, Pruneri G, Galli GG, Magnani L. A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer Evolution. Cancer Discov. 2024 Sep 4;14(9):1612-1630. doi: 10.1158/2159 8290.CD-23-1157. PMID: 38753319; PMCID: PMC11372371.
40: Vékony B, Nyirő G, Herold Z, Fekete J, Ceccato F, Gruber S, Kürzinger L, Parasiliti-Caprino M, Bioletto F, Szücs N, Doros A, Szeredás BK, Syed Mohammed Nazri SK, Fell V, Bassiony M, Dank M, Azizan EA, Bancos I, Beuschlein F, Igaz P. Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism. Hypertension. 2024 Oct 17. doi: 10.1161/HYPERTENSIONAHA.124.23418. Epub ahead of print. PMID: 39417220.
41: Barreca M, Dugo M, Galbardi B, Győrffy B; NA-PHER2 consortium; NeoTRIP consortium; Valagussa P, Besozzi D, Viale G, Bianchini G, Gianni L, Callari M. Development and validation of a gene expression-based Breast Cancer Purity Score. NPJ Precis Oncol. 2024 Oct 24;8(1):242. doi: 10.1038/s41698-024-00730-7. PMID: 39448787; PMCID: PMC11502849.
42: Diossy M, Tisza V, Li H, Sahgal P, Zhou J, Sztupinszki Z, Young D, Nousome D, Kuo C, Jiang J, Chen Y, Ebner R, Sesterhenn IA, Moncur JT, Chesnut GT, Petrovics G, Klus GT, Valcz G, Nuzzo PV, Ribli D, Börcsök J, Prosz A, Krzystanek M, Ried T, Szuts D, Rizwan K, Kaochar S, Pathania S, D’Andrea AD, Csabai I, Srivastava S, Freedman ML, Dobi A, Spisak S, Szallasi Z. Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression. NPJ Precis Oncol. 2024 Sep 19;8(1):208. doi: 10.1038/s41698-024-00705-8. PMID: 39294262; PMCID: PMC11411125.
43: Puttick C, Jones TP, Leung MM, Galvez-Cancino F, Liu J, Varas-Godoy M, Rowan A, Pich O, Martinez-Ruiz C, Bentham R, Dijkstra KK, Black JRM, Rosenthal R, Kanu N, Litchfield K, Salgado R, Moore DA, Van Loo P, Jamal-Hanjani M, Quezada SA; TRACERx Consortium; Swanton C, McGranahan N. MHC Hammer reveals genetic and non- genetic HLA disruption in cancer evolution. Nat Genet. 2024 Oct;56(10):2121-2131. doi: 10.1038/s41588-024-01883-8. Epub 2024 Oct 2. PMID: 39358601; PMCID: PMC11525181.
44: Ungvari Z, Fekete M, Varga P, Lehoczki A, Fekete JT, Ungvari A, Győrffy B. Overweight and obesity significantly increase colorectal cancer risk: a meta- analysis of 66 studies revealing a 25-57% elevation in risk. Geroscience. 2024 Oct 8. doi: 10.1007/s11357-024-01375-x. Epub ahead of print. PMID: 39379738.
45: Ungvari Z, Ungvari A, Fekete M, Kiss C, Győrffy B. Senescence-related genes as prognostic indicators in breast cancer survival. Geroscience. 2024 Oct 21. doi: 10.1007/s11357-024-01384-w. Epub ahead of print. PMID: 39432147.